Literature DB >> 25600543

Interferon gamma release assays and tubercolin skin test performance in different settings of HIV immunodeficiency.

Roberto Parrella1, Vincenzo Esposito2, Mirella Onofrio2, Giovanni Parrella2, Rosaria Viglietti2, Vincenzo Sangiovanni2, Miriam Gargiulo2, Filomena Di Martino2, Annalisa Del Giudice3, Giulia Santoro3, Mariano Bernardo3, Maria Aurora Carleo2, Antonio Chirianni2.   

Abstract

BACKGROUND/AIM: HIV infection is a risk factor for re-activation of latent tubercolosis infection (LTBI). In recent years new blood tests for the detection of TB infection have been developed: Quantiferon TB Gold in Tube and TSPOT TB, which are interferon-γ releasing assays (IGRAs), have improved the identification of LTBI. In our study we have compared IGRAs and TST in HIV-positive patients with different settings of immunodeficiency. PATIENTS AND METHODS: 98 consecutive HIV patients were recruited. They underwent a blood draw, a chest radiography and a tuberculin skin test. The HIV infection setting was detected and IGRAs were carried-out. Five patients showed a complete correspondence of TST, TSPOT-TB and QFT-IT. Discordant results were observed in patients testing positive to IGRAs but negative to TST. Only 2 patients showed positive TST and negative IGRAs.
CONCLUSION: Our study showed a poor concordance between tuberculin skin test and IGRAs, mainly in patients with a low CD4 cell count.
Copyright © 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  HIV infection; Latent tubercolosis infection; interferon gamma releasing assays; tuberculin skin test

Mesh:

Year:  2015        PMID: 25600543

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  1 in total

Review 1.  Diagnostic Value of Interferon-Gamma Release Assays for Tuberculosis in the Immunocompromised Population.

Authors:  Ying Yang; Hong-Jiao Wang; Wei-Lin Hu; Guan-Nan Bai; Chun-Zhen Hua
Journal:  Diagnostics (Basel)       Date:  2022-02-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.